CAMERON REAVES: Open Payments
NPI 1528692100 · APEX, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,337 in 79 payments from 21 companies in 2025. Trend: 2023 $2,287 · 2024 $2,859 · 2025 $1,337
Food & beverage: $1,337
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $185 |
| Otsuka America Pharmaceutical, Inc. | 10 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $149 |
| Corium, LLC | 6 | $132 |
| Lundbeck LLC | 4 | $73 |
| Collegium Pharmaceutical, Inc. | 4 | $73 |
| E.R. Squibb & Sons, L.L.C. | 4 | $71 |
| Axsome Therapeutics, Inc. | 4 | $68 |
| Vanda Pharmaceuticals Inc. | 3 | $64 |
| Supernus Pharmaceuticals, Inc. | 4 | $64 |
Products named: REXULTI, CAPLYTA, VRAYLAR, Azstarys, Jornay PM, COBENFY, Auvelity, Qelbree.
Industry payments across NC — which companies pay providers there.
